Antibiotic resistance | UNESCO honours Moroccan researcher Adnane Remmal

Adnane Remmal, a pharmacologist and microbiologist at Sidi Mohamed Ben Abdellah University in Fez, received the 2026 UNESCO–Equatorial Guinea International Prize for Research in the Life Sciences in Paris on 6 November. The award recognises work that has led to a medicine authorised in Morocco and to products designed to reduce antibiotic use in livestock farming.

UNESCO honoured a scientist who has devoted much of his career to a pressing public health question. How can antibiotics remain effective as bacteria develop resistance? Remmal has pursued two lines of research, one aimed at improving the action of existing antibiotics and the other at reducing reliance on them in livestock farming. He shared the tenth edition of the prize with neuroscientist Nancy Yuk-yu Ip, recognised for her work on Alzheimer’s disease, and Spanish professor Carlos Martín Montañés, recognised for his research on a tuberculosis vaccine.

From a university laboratory in Fez to pharmaceutical production

Remmal studied the antimicrobial properties of certain compounds found in essential oils and investigated whether combining one of them with an antibiotic could enhance its action. The research led to OLIPEN®, a medicine that combines an antibiotic with a compound derived from an essential oil and is authorised for clinical use in Morocco. Figures released on the occasion of the award put the number of patients who have received the medicine in Morocco at more than 500,000.

Moroccan pharmaceutical company Sothema handled industrial development and took the medicine through the regulatory steps that led to its authorisation and commercial launch. The partnership shows how an invention originating at a Moroccan university found the pharmaceutical expertise it needed within the country to move from the laboratory to the market.

Reducing reliance on antibiotics in livestock farming

The second strand of Remmal’s research focuses on animal health. He developed plant extract-based products intended to reduce antibiotic use in livestock farming. That research led to the establishment of LIAV, a company that manufactures and markets products for livestock producers.

The two strands come together under the One Health approach. In human medicine, Remmal’s work explores treatment options for infections caused by resistant bacteria. In livestock farming, it aims to reduce antibiotic use and ease the pressure that favours the survival and spread of resistant bacteria. Farm practices and patient care can both help preserve the effectiveness of these medicines.

Each strand had already earned Remmal international recognition. In 2015, the Innovation Prize for Africa honoured his work on a livestock feed supplement. In 2017, he received the European Inventor Award’s Popular Prize for his research on enhancing the action of antibiotics. The UNESCO prize recognises both contributions as part of the same scientific endeavour.

A career in science and entrepreneurship rooted in Fez

Born in Fez, Remmal joined Paris-XI University in Orsay in 1982. After earning a doctorate in molecular pharmacology in 1987, he returned to Morocco and joined Sidi Mohamed Ben Abdellah University the following year. He taught cell biology, microbiology and molecular biology. His research into the antimicrobial activity of essential oils earned him a second doctorate, in microbiology, in 1994.

Remmal co-founded Advanced Scientific Developments to manage patents arising from his laboratory’s work. He went on to help establish LIAV, which has its own manufacturing facility, to bring the livestock products to market. The medicine for human use reached the market through the partnership with Sothema. Alongside this work, Remmal trained dozens of researchers who now work in Morocco and abroad.

The distinction also brings attention to the institutions and businesses that helped develop his research in Morocco. The university supported the work and trained scientists, a company managed the patents, a pharmaceutical manufacturer developed the medicine and a specialist business brought the livestock products into production. The Paris award honours a body of research that found practical applications within the country where it took shape.

Most recent articles

Also to read